GSK
927 hedge funds and large institutions have $14.4B invested in GSK in 2022 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 351 increasing their positions, 273 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
927
Holders Change
+10
Holders Change %
+1.09%
% of All Funds
14.67%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.27%
New
103
Increased
351
Reduced
273
Closed
79
Calls
$342M
Puts
$206M
Net Calls
+$136M
Net Calls Change
-$255M
Top Buyers
| 1 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
+$132M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$103M |
| 3 |
Goldman Sachs
New York
|
+$101M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$97.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$70.2M |
